US Bill Recap: What Are The Latest Legislation Moves Covering Generics And Biosimilars?
The US Congress Halls Have Been Buzzing With New Developments In September
Executive Summary
Generics Bulletin reviews several critical US bills and the off-patent industry’s response, along with budget calculations and new proposals.